Categories
Anticancer Drugs Oncology Palonosetron Pharmacology Physiotherapy

Palonosetron (Drug Interaction Studies)

In this article we will discuss Palonosetron (Drug Interaction Studies)

In this article, we will discuss Palonosetron (Drug Interaction Studies). So, let’s get started.

Palonosetron (Drug Interaction Studies)

In vitro studies indicated that palonosetron is not an inhibitor of CYP1A2, CYP2A6,
CYP2B6, CYP2C9, CYP2D6, CYP2E1 and CYP3A4/5 (CYP2C19 was not investigated)
nor does it induce the activity of CYP1A2, CYP2D6, or CYP3A4/5. Therefore, the
potential for clinically significant drug interactions with palonosetron appears to be low.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.